Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind, Controlled Pilot Study on Safety of Hypertonic Saline as Preventive Inhalation Therapy in Newborns and Infants With Cystic Fibrosis

NCT01619657 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.

NCT NCT01619657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01619657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind, Controlled Pilot Study on Safety of Hypertonic Saline as Preventive Inhalation Therapy in Newborns and Infants With Cystic Fibrosis
Lead sponsor
Heidelberg University
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2012
Completion date
October 31, 2017
Enrollment
42 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis lung disease